However, in all the studied populations, the prevalence of PTEN mutations in hyperplasias was even lower compared to endometrioid carcinoma, namely, 33.3% in Poland [23] and 9.6% in Japan [21]. Here, PTEN is linked to endometrioid adenocarcinoma.